MJ, Cotter DR. Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry. 2011;68(50) labeled sample (25 μg each) were run alongside a Cy2 labeled internal standard (25 μg), making a total protein loading of 75 μg per gel (Please see eTable 2 for the study design). Following IEF the gels were separated by SDS-PAGE using 12% separating polyacrylamide gel using the Biorad Protean Plus Dodeca Cell system (Amersham Biosciences, GE Healthcare, UK).
Blots were incubated with ECL chemiluminescent reagent (Amersham Biosciences), exposed to Xray film and developed accordingly. Levels of expression were quantified and normalized against anti-(rabbit) ERK2 (1:8000, Santa Cruz Biotechnology).
Dot blot
For FSCN1 1 μg of protein from 20 samples each of CA2/3 from schizophrenia, bipolar disorder and control cases were dotted onto nylon membranes. Rabbit anti (human) Fascin1 (1:2000, Santa Cruz Biotechnology) was used as a primary antibody, incubated over night at 4º C, washed as described, then incubated with the corresponding horseradish peroxidase-conjugated secondary antibody (anti-rabbit IgG (1:2000 dilution, Promega) and detected with diamino benzidine (Sigma Aldrich Ireland Ltd.).
ELISA
For protein PCMT1, we employed ELISA 8 as described by us previously 9 . Briefly, protein coated plates were incubated with PCMT1 primary antibody (Abcam, 1:400) overnight; samples of 20 samples each of schizophrenia, bipolar disorder and control were incubated with the appropriate secondary anti-HRP-linked IgG, for 2 h at room temperature, and incubated with 100 μL/well of TMB Super Sensitive HP Substrate (ImmunoChemistry Technologies, Bloomington, USA) for 15 min at room temperature. The absorbance of standards, samples, and negative controls was read at 620 nm on a plate reader.
Validation of differentially expressed proteins in Haloperidol-treated mice
To assess the effects of psychotropic medication on the expression of candidate proteins, hippocampal tissue was harvested from mice treated with haloperidol [10] [11] [12] . For chronic treatment, seven male C57BL/6 mice, at 10 weeks of age, were injected daily intraperitoneally with 0.5 mg/kg of haloperidol, for 28 days. A control group of seven animals was injected with vehicle only (saline). Immediately after decapitation the hippocampus was dissected, snap frozen in liquid nitrogen, and stored at -80°C. Ethical approval (application no. REC175) was granted by the RCSI Research Ethics Committee. Western Blotting was undertaken on mouse hippocampal tissue homogenates for Annexin6, Fascin1, PCMT1, Septin11 and Spectrin.
Western Blotting was undertaken on mouse hippocampal tissue homogenates using primary antibodies to Fascin, Spectrin, Annexin, Septin11 as described above except for PCMT1, where an anti-rabbit antibody was used (dilution 1: 1000, ProteinTech Europe Ltd., Manchester, UK).
Statistical Analysis of validation work
For western blot analysis, density values were measured and corrected by the signal intensity of the respective antibody to ERK2. For Armadillo, Fascin1 and PCMT1 expression data (for which we had case-wise information) values obtained from each condition were compared using a two-way analysis of co-variance (ANCOVA) which took disease,independent replicates, and the covariates postmortem interval, brain pH, and refrigerator interval into account. For the other proteins used for validation (Annexin6, Spectrin and Septin11) we used the same methods, but did not correct for covariates, as samples were pooled. Statistical significance was set at the 5% level.
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